This statistic shows the average length of a clinical trial cycle from 2020 to 2024, in months. The data is based on the top 20 biopharma companies by R&D spend. As can be seen, the average length of trials increased, with a peak of over 100 months in 2024.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Deloitte. (March 27, 2025). Average length of a clinical trial cycle from 2020 to 2024 (in months) [Graph]. In Statista. Retrieved May 09, 2026, from https://www.statista.com/statistics/1419920/biopharma-clinical-trial-cycle-time/
Deloitte. "Average length of a clinical trial cycle from 2020 to 2024 (in months)." Chart. March 27, 2025. Statista. Accessed May 09, 2026. https://www.statista.com/statistics/1419920/biopharma-clinical-trial-cycle-time/
Deloitte. (2025). Average length of a clinical trial cycle from 2020 to 2024 (in months). Statista. Statista Inc.. Accessed: May 09, 2026. https://www.statista.com/statistics/1419920/biopharma-clinical-trial-cycle-time/
Deloitte. "Average Length of a Clinical Trial Cycle from 2020 to 2024 (in Months)." Statista, Statista Inc., 27 Mar 2025, https://www.statista.com/statistics/1419920/biopharma-clinical-trial-cycle-time/
Deloitte, Average length of a clinical trial cycle from 2020 to 2024 (in months) Statista, https://www.statista.com/statistics/1419920/biopharma-clinical-trial-cycle-time/ (last visited May 09, 2026)
Average length of a clinical trial cycle from 2020 to 2024 (in months) [Graph], Deloitte, March 27, 2025. [Online]. Available: https://www.statista.com/statistics/1419920/biopharma-clinical-trial-cycle-time/
